Claire Thorp Email & Phone Number

Dana Point, Ca, Us

During my tenure here, I guided and helped over 20 healthcare clients through complex reimbursement landscapes and innovative technologies. My expertise spans strategic consulting, high-stakes negotiations, and relationship management with key stakeholders in the healthcare sector. By leveraging an in-depth knowledge of market trends and payer dynamics, I have consistently enhanced product portfolios and unlock new business opportunities for firms like Invitae, Veracyte, and Guardant Health.At a leading biotech firm, I orchestrated the strategic selection and integration of billing entities, which resulted in significant cost savings and ensured financial sustainability amidst challenging zero-coverage policies. My initiative involved meticulous research and evaluation to pinpoint the optimal billing partner, culminating in a streamlined process that fortified the firm’s financial footing and operational efficiency.I spearheaded market access initiatives for another major biotech corporation, where I secured crucial contracts with top payers including Anthem and BCBSA. This role required adept negotiation skills and a strategic understanding of payer requirements and expectations. My efforts not only solidified foundational payer relationships but also established a robust framework for sustained coverage and reimbursement that supported the corporation's long-term business objectives.In a project with a San Diego-based laboratory, I demonstrated exceptional problem-solving skills by designing a business plan focused on immediate financial returns and long-term payer engagement. Through developing a comprehensive reimbursement strategy supported by solid evidence, I set a foundation for continuous engagement with payers. This project not only addressed immediate financial needs but also paved the way for enduring relationships with key decision-makers.

At the forefront of business development for a burgeoning IT healthcare startup, I led initiatives in B2B negotiations and early-stage market entry, establishing foundational agreements with managed care providers to secure optimal reimbursement terms. My efforts were crucial in defining and promoting our value proposition and enhancing market coverage for our innovative medical tests and services.Through strategic negotiations, I achieved a landmark success by securing three major accounts in one day, underscoring the effectiveness of our business model and affirming our potential to key stakeholders. My focus on understanding and addressing the unique needs of diverse medical practices enabled me to introduce our services strategically to underserved communities, thereby bolstering our company's reputation for cultural competence and market responsiveness.My role not only involved the orchestration of complex contract negotiations but also the implementation of tailored business strategies that aligned with the dynamic needs of the healthcare market. This approach not only expanded our company's footprint but also positioned us as a key player in the IT healthcare sector.

Chicago, Il, Us

In my role at Tempus Labs, I executed key contracting processes, particularly for molecular sequencing panel testing, enhancing our service delivery and operational efficiency. I introduced an innovative pricing grid and implemented a medical policy tracking system that optimized our strategic positioning and market response.I also played a pivotal role in developing and deploying a market access training module tailored for the Sales team, significantly boosting their performance and aiding in meeting ambitious revenue goals. My regular presentations to executive leadership on strategic initiatives ensured transparency and fostered informed decision-making.Collaborating closely with cross-functional teams, I ensured that all strategic initiatives were aligned and effectively executed. My leadership in prolonged negotiations with major healthcare providers, including Kaiser Permanente, not only solidified long-term partnerships but also expanded our market influence and accessibility to advanced healthcare solutions.

Here, I leveraged cutting-edge peer-reviewed data and HTAs to expand market access and ensure our products met clinical and economic value benchmarks. I tailored strategic engagements with major payers, optimizing relationships with key decision-makers to bolster recognition and support for our offerings.I devised and implemented a comprehensive strategic marketing plan aimed at enhancing payer engagement and policy acceptance. This multifaceted plan included the development of payer and training decks, an evidence list, a national pricing grid, and a meticulously planned HTA calendar. These tools were crucial in addressing cost barriers and technical challenges, significantly improving payer interactions and policy endorsements.In a notable achievement, I led the initiative to establish the second favorable commercial medical policy for Corus CAD, a groundbreaking cardiac diagnostic assay, with Blue Shield of CA in the first quarter of 2019. This success was pivotal in strengthening market access and enhancing the viability of our company in the competitive healthcare landscape.My leadership extended to enhancing the performance of the Sales team by providing targeted education and support in managed care, medical policy, and contracting. I managed task delegation, conducted performance assessments, and led effective feedback sessions. My efforts not only boosted team capabilities but also aligned sales strategies with broader company goals, leading to improved outcomes and team cohesion.

Redwood City, Ca, Us

In this role, I spearheaded market access initiatives that transformed the landscape of genomic assays in oncology. My strategic acumen and leadership were pivotal in negotiating and maintaining robust partnerships with key national HTA's and payers like BCBSA and Kaiser Permanente.One of my key accomplishments was orchestrating a state-wide policy change in California that secured test coverage for cancer patients. This initiative not only expanded access but also demonstrated the tangible impact of genomic assays on patient care. By presenting compelling, peer-reviewed evidence and leading robust discussions with key opinion leaders, I successfully navigated complex payer negotiations. This not only secured coverage but also facilitated a $4M recovery in previously denied claims each quarter, markedly enhancing revenue streams.Another significant achievement was my strategic leadership in the rollout of new genomic tests for prostate and colon cancer, which were established as the standard of care within eight years. This initiative required a careful blend of market analysis, stakeholder engagement, and strategic marketing. By directly engaging with medical communities and leveraging data-driven insights, I ensured these genomic health assays were adopted widely, enhancing our market presence and solidifying our leadership in oncology diagnostics.Throughout my tenure, my ability to maintain strong pricing integrity without offering discounts showcases my negotiation skills and a firm grasp of market dynamics. By holding firm in negotiations with major payers, including securing annual price increases, I not only preserved our pricing structure but also boosted profitability. My approach often involved challenging misleading competitive claims and debunking them with decisive evidence, a testament to my commitment to ethical standards and truth in medical advancement.